Mymetics Corp. is a biotechnology company, which engages in the research and development of virosome based vaccines. It focuses on next generation vaccines for infectious and life disabling diseases. The company was founded in July 1994 and is headquartered in Epalinges, Switzerland.
This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.
$0.03 OTCQB
As of 01/30/2023 OTCMarkets
2022 © Stock Market MBA, Inc.